2-PYRIDONE COMPOUND

This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect: and is useful as a pharmaceutical.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Takumi OKADA, Tomomichi CHONAN, Marie MIZUTANI, Keiko FUSEGI, Hajime ASANUMA, Hirofumi OTA, Shoichi KURODA, Souichi MONMA, Masahiro BOHNO, Seishi ISHIYAMA, Yudai IMAI, Takanori KAWAGUCHI, Nagaaki SATO, Shigetada SASAKO, Shin ITOH
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Takumi OKADA
Tomomichi CHONAN
Marie MIZUTANI
Keiko FUSEGI
Hajime ASANUMA
Hirofumi OTA
Shoichi KURODA
Souichi MONMA
Masahiro BOHNO
Seishi ISHIYAMA
Yudai IMAI
Takanori KAWAGUCHI
Nagaaki SATO
Shigetada SASAKO
Shin ITOH
description This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect: and is useful as a pharmaceutical.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MY173812A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MY173812A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MY173812A3</originalsourceid><addsrcrecordid>eNrjZBA20g2IDPJ08fdzVXD29w3wD_Vz4WFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8b6RhubGFoZGjsYEFQAAsB8dOA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-PYRIDONE COMPOUND</title><source>esp@cenet</source><creator>Takumi OKADA ; Tomomichi CHONAN ; Marie MIZUTANI ; Keiko FUSEGI ; Hajime ASANUMA ; Hirofumi OTA ; Shoichi KURODA ; Souichi MONMA ; Masahiro BOHNO ; Seishi ISHIYAMA ; Yudai IMAI ; Takanori KAWAGUCHI ; Nagaaki SATO ; Shigetada SASAKO ; Shin ITOH</creator><creatorcontrib>Takumi OKADA ; Tomomichi CHONAN ; Marie MIZUTANI ; Keiko FUSEGI ; Hajime ASANUMA ; Hirofumi OTA ; Shoichi KURODA ; Souichi MONMA ; Masahiro BOHNO ; Seishi ISHIYAMA ; Yudai IMAI ; Takanori KAWAGUCHI ; Nagaaki SATO ; Shigetada SASAKO ; Shin ITOH</creatorcontrib><description>This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect: and is useful as a pharmaceutical.</description><language>eng</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200224&amp;DB=EPODOC&amp;CC=MY&amp;NR=173812A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200224&amp;DB=EPODOC&amp;CC=MY&amp;NR=173812A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Takumi OKADA</creatorcontrib><creatorcontrib>Tomomichi CHONAN</creatorcontrib><creatorcontrib>Marie MIZUTANI</creatorcontrib><creatorcontrib>Keiko FUSEGI</creatorcontrib><creatorcontrib>Hajime ASANUMA</creatorcontrib><creatorcontrib>Hirofumi OTA</creatorcontrib><creatorcontrib>Shoichi KURODA</creatorcontrib><creatorcontrib>Souichi MONMA</creatorcontrib><creatorcontrib>Masahiro BOHNO</creatorcontrib><creatorcontrib>Seishi ISHIYAMA</creatorcontrib><creatorcontrib>Yudai IMAI</creatorcontrib><creatorcontrib>Takanori KAWAGUCHI</creatorcontrib><creatorcontrib>Nagaaki SATO</creatorcontrib><creatorcontrib>Shigetada SASAKO</creatorcontrib><creatorcontrib>Shin ITOH</creatorcontrib><title>2-PYRIDONE COMPOUND</title><description>This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect: and is useful as a pharmaceutical.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBA20g2IDPJ08fdzVXD29w3wD_Vz4WFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8b6RhubGFoZGjsYEFQAAsB8dOA</recordid><startdate>20200224</startdate><enddate>20200224</enddate><creator>Takumi OKADA</creator><creator>Tomomichi CHONAN</creator><creator>Marie MIZUTANI</creator><creator>Keiko FUSEGI</creator><creator>Hajime ASANUMA</creator><creator>Hirofumi OTA</creator><creator>Shoichi KURODA</creator><creator>Souichi MONMA</creator><creator>Masahiro BOHNO</creator><creator>Seishi ISHIYAMA</creator><creator>Yudai IMAI</creator><creator>Takanori KAWAGUCHI</creator><creator>Nagaaki SATO</creator><creator>Shigetada SASAKO</creator><creator>Shin ITOH</creator><scope>EVB</scope></search><sort><creationdate>20200224</creationdate><title>2-PYRIDONE COMPOUND</title><author>Takumi OKADA ; Tomomichi CHONAN ; Marie MIZUTANI ; Keiko FUSEGI ; Hajime ASANUMA ; Hirofumi OTA ; Shoichi KURODA ; Souichi MONMA ; Masahiro BOHNO ; Seishi ISHIYAMA ; Yudai IMAI ; Takanori KAWAGUCHI ; Nagaaki SATO ; Shigetada SASAKO ; Shin ITOH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MY173812A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Takumi OKADA</creatorcontrib><creatorcontrib>Tomomichi CHONAN</creatorcontrib><creatorcontrib>Marie MIZUTANI</creatorcontrib><creatorcontrib>Keiko FUSEGI</creatorcontrib><creatorcontrib>Hajime ASANUMA</creatorcontrib><creatorcontrib>Hirofumi OTA</creatorcontrib><creatorcontrib>Shoichi KURODA</creatorcontrib><creatorcontrib>Souichi MONMA</creatorcontrib><creatorcontrib>Masahiro BOHNO</creatorcontrib><creatorcontrib>Seishi ISHIYAMA</creatorcontrib><creatorcontrib>Yudai IMAI</creatorcontrib><creatorcontrib>Takanori KAWAGUCHI</creatorcontrib><creatorcontrib>Nagaaki SATO</creatorcontrib><creatorcontrib>Shigetada SASAKO</creatorcontrib><creatorcontrib>Shin ITOH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Takumi OKADA</au><au>Tomomichi CHONAN</au><au>Marie MIZUTANI</au><au>Keiko FUSEGI</au><au>Hajime ASANUMA</au><au>Hirofumi OTA</au><au>Shoichi KURODA</au><au>Souichi MONMA</au><au>Masahiro BOHNO</au><au>Seishi ISHIYAMA</au><au>Yudai IMAI</au><au>Takanori KAWAGUCHI</au><au>Nagaaki SATO</au><au>Shigetada SASAKO</au><au>Shin ITOH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-PYRIDONE COMPOUND</title><date>2020-02-24</date><risdate>2020</risdate><abstract>This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect: and is useful as a pharmaceutical.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_MY173812A
source esp@cenet
title 2-PYRIDONE COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T05%3A39%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Takumi%20OKADA&rft.date=2020-02-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMY173812A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true